Spondyloarthropathies: Targeted therapy for psoriatic arthritis.
Tumor necrosis factor inhibitors are an effective treatment for psoriatic arthritis, but no single agent is effective in all patients. Novel therapies that target other cytokines have now been tested, with encouraging results.
Gladman
Dafna D
DD
University of Toronto and Toronto Western Research Institute, Toronto, ON, Canada. dafna.gladman@utoronto.ca
D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D017326:Clinical Trials, Phase III as Topic; D016503:Drug Delivery Systems; D004351:Drug Resistance; D004361:Drug Tolerance; D006801:Humans; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents